Laboratory identification of hereditary risk of breast and ovarian cancer
- 30 June 1999
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 10 (3) , 289-294
- https://doi.org/10.1016/s0958-1669(99)80051-2
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Oral Contraceptives and the Risk of Hereditary Ovarian CancerNew England Journal of Medicine, 1998
- Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.Journal of Clinical Oncology, 1998
- Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.Journal of Clinical Oncology, 1998
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- Genetic Testing for Cancer RiskScience, 1997
- From Bench Top to BedsideScience, 1997
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1Science, 1994
- Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21Science, 1990
- Isolation of a transforming sequence from a human bladder carcinoma cell lineCell, 1982